Vera Therapeutics, Inc. (VERA)
34.04
-0.31
(-0.90%)
USD |
NASDAQ |
May 22, 16:00
33.88
-0.16
(-0.47%)
Pre-Market: 20:00
Vera Therapeutics Shareholders Equity (Quarterly) : 499.70M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Cogent Biosciences, Inc. | 607.69M |
| Syndax Pharmaceuticals, Inc. | 41.62M |
| United Therapeutics Corp. | 5.901B |
| Biogen, Inc. | 18.65B |
| Cytokinetics, Inc. | -826.57M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 621.74M |
| Total Liabilities (Quarterly) | 122.04M |
| Debt to Equity Ratio | 0.1501 |
| Current Ratio | 13.47 |
| Net Debt Paydown Yield | -0.14% |